• PRS47 COMPARING RISK ADJUSTMENT MODELS- PROPENSITY SCORE MATCHING, STANDARD REGRESSION ANALYSIS AND INSTRUMENTAL VARIABLE METHOD

    May 1, 2010, 00:00

  • PMC21 PATIENT-REPORTED OUTCOMES IN PRODUCT DEVELOPMENT GUIDANCE

    May 1, 2010, 00:00

  • PCN137 CHARACTERISTICS OF PATIENTS AND PREDICTORS OF IN-HOSPITAL MORTALITY AFTER HOSPITALIZATION FOR LUNG CANCER IN WEST VIRGINIA

    May 1, 2010, 00:00

  • PSS5 COST-EFFECTIVENESS STUDY ON THE USE OF TERBINAFINE VS. ITRACONAZOLE IN THE TREATMENT OF ONYCHOMYCOSIS IN MEXICO- AN INSTITUTIONAL PERSPECTIVE BASED ON THE RESULTS OF THE L.I.O.N. STUDY

    May 1, 2010, 00:00

  • PCV134 READMISSIONS AFTER UNAUTHORIZED DISCHARGES IN THE CARDIOVASCULAR SETTING

    May 1, 2010, 00:00

  • PMC44 AN EVALUATION OF THE STATISTICAL EFFICIENCY OF THE US POPULATION MEDIAN-BASED EQ-5D INDEX USING DATA FROM THE MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2010, 00:00

  • PMH34 DIRECT HEALTH CARE COSTS AMONG PATIENTS WITH BIPOLAR DISORDER WHO INITIATED THERAPY WITH ARIPIPRAZOLE OR QUETIAPINE XR

    May 1, 2010, 00:00

  • PCV121 THE IMPACT OF PART D ON PREVIOUSLY UNINSURED MEDICARE BENEFICIARIES WITH HYPERTENSION

    May 1, 2010, 00:00

  • PMH79 STATISTICAL ANALYSIS OF DIAGNOSIS RELATED GROUP 521- ALCOHOL/DRUG ABUSE OR DEPENDENCE WITH COMPLICATIONS AND COMORBIDITIES

    May 1, 2010, 00:00

  • PMH58 ASSESSMENT OF HEALTH CARE UTILIZATION AND COST AMONG PATIENTS WITH BIPOLAR I DISORDER TREATED WITH ANTIPSYCHOTIC THERAPY IN A MULTISTATE MEDICAID POPULATION

    May 1, 2010, 00:00

  • PHP79 INNOVATIVE PRICING AGREEMENTS IN UK NICE SUBMISSIONS

    May 1, 2010, 00:00

  • PCN25 THE BUDGETARY IMPACT OF PEMETREXED MAINTENANCE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER

    May 1, 2010, 00:00

  • PMH48 VALIDATING A COST-EFFECTIVENESS ANALYSIS COMPARING OLANZAPINE WITH ZIPRASIDONE IN THE TREATMENT OF SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PCN132 COST OF BREAST AND CERVICAL CANCER TREATMENT AND FOLLOW-UP CARE IN MEDICAID BENEFICARIES- IMPLICATIONS FOR STATE PROGRAMS PROVIDING COVERAGE FOR LOW-INCOME WOMEN

    May 1, 2010, 00:00

  • PND17 ECONOMIC EVALUATION OF THE IMPACT OF MEMANTINE ON TIME TO NURSING HOME ADMISSION IN THE TREATMENT OF ALZHEIMERS DISEASE

    May 1, 2010, 00:00

  • PCN143 COST-EFFECTIVENESS OBSERVATIONS AND ONCOLOGY DRUG REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE JOINT ONCOLOGY DRUG REVIEW

    May 1, 2010, 00:00

  • PCV159 COMPARATIVE EFFECTIVENESS INDEX- A CONCEPTUAL APPROACH TO COMPARATIVE EFFECTIVENESS RESEARCH

    May 1, 2010, 00:00

  • PRS20 THE ECONOMIC BURDEN OF CHRONIC DISEASES IN ADULT US WORKERS IN TERMS OF MEDICAL EXPENDITURE AND LOST PRODUCTIVITY COSTS

    May 1, 2010, 00:00

  • PND40 THE IMPORTANCE OF GUIDELINES FOR CLINROS- THE ADAS-COG, A CASE STUDY

    May 1, 2010, 00:00

  • PHP48 PHYSICIANS PERCEPTION OF MEDICAID PAYMENTS AND WILLINGNESS TO ACCEPT NEW MEDICAID PATIENTS

    May 1, 2010, 00:00

  • PCV139 EVALUATION OF A HEALTH CARE PROVIDER INTERVENTION TO INITIATE ACEI OR ARB THERAPY AMONG PATIENTS WITH DIABETES PLUS HYPERTENSION AND/OR NEPHROPATHY

    May 1, 2010, 00:00

  • PCN31 COST COMPARISON OF INPATIENT AND OUTPATIENT HOSPITALBASED SERVICES BETWEEN TWO STRATEGIES FOR TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN A PUBLICLY FUNDED HEALTH CARE SYSTEM

    May 1, 2010, 00:00

  • PMC35 ISSUES IN THE TRANSLATION AND LINGUISTIC VALIDATION OF EPRO AND IVRS INSTRUMENTS

    May 1, 2010, 00:00

  • CASE4 NEW FINDINGS FROM INTEGRATING ADMINISTRATIVE AND FINANCIAL DATABASES TO ESTIMATE PRICE OF HOSPITALIZATIONS

    May 1, 2010, 00:00

  • PMH50 COSTS AND EFFECTS OF ILOPERIDONE COMPARED WITH OLANZAPINE AND HALOPERIDOL IN PATIENTS WITH ACUTE SCHIZOPHRENIA- RESULTS FROM A COST-EFFECTIVENESS MARKOV MODEL

    May 1, 2010, 00:00

  • PSY12 COMPARISON OF ABSENTEEISM AND TOTAL HEALTH CARE EXPENDITURES FOR SELECT AUTO-IMMUNE INFLAMMATORY DISORDERS (AMD) PRE AND POST ANTI-TNF USE-AN EMPLOYERS PERSPECTIVE

    May 1, 2010, 00:00

  • PCV151 ASSESSMENT OF MEDICATION UTILIZATION PATTERN OF PATIENTS WITH SYSTOLIC HYPERTENSION AND COMPELLING INDICATIONS IN A PRIMARY CARE PRACTICE

    May 1, 2010, 00:00

  • PCN65 A COST-EFFECTIVENESS ANALYSIS OF THE FIRST-LINE TREATMENT REGIMENS FOR MULTIPLE MYELOMA IN MACAO CHINA

    May 1, 2010, 00:00

  • CV2 USING AN INTERRUPTED TIME SERIES ANALYSIS TO ASSESS THE IMPACT OF VALSARTAN INITIATION ON MEDICAL COSTS FOR PATIENTS WITH HYPERTENSION

    May 1, 2010, 00:00

  • PGI15 MEDICAL SERVICE UTILIZATION AND COSTS BY DISEASE SEVERITY, SUSTAINED VIRAL RESPONSE, AND GENOTYPE IN EUROPEAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS

    May 1, 2010, 00:00

  • PCN105 PATIENT PREFERENCE-BASED UTILITY WEIGHTS FROM THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY-GENERAL (FACT-G) IN WOMEN WITH HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER RECEIVING LETROZOLE PLUS LAPATINIB OR LETROZOLE ALONE

    May 1, 2010, 00:00

  • PUK19 ECONOMIC EVALUATION OF PERITONEAL DIALYSYS COMPARED WITH HEMODIALYSIS IN PATIENTS WITH CHRONIC KIDNEY DISEASE SECONDARY TO DIABETES OR HYPERTENSION IN COLOMBIA

    May 1, 2010, 00:00

  • PCN30 EFFECTS OF ADDING CHEMOTHERAPY-SPECIFIC DISCONTINUATION AND DOSE DELAY/REDUCTIONS TO FEBRILE NEUTROPENIA PROPHYLAXIS DECISION MODELS

    May 1, 2010, 00:00

  • PRS35 COMPARISON OF PATIENT REPORTED OUTCOMES BASED ON THE MINNESOTA NICOTINE WITHDRAWAL SCALE (MNWS) USING ABSTINENCE PROFILES IN TREATMENTS WITH VARENICLINE AND TRANSDERMAL NICOTINE PATCH (NRT)

    May 1, 2010, 00:00

  • CM1 ADHERENCE, DISCONTINUATION, AND SWITCHING OF BIOLOGIC THERAPIES IN MEDICAID ENROLLEES WITH RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00

  • PCV86 COST-UTILITY ANALYSIS OF RIVAROXABAN COMPARED WITH ENOXAPARIN IN PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN SLOVAKIA

    May 1, 2010, 00:00

  • PMH21 PREVALENCE AND PREDICTORS OF ANTICHOLINERGIC MEDICATION USE IN ELDERLY NURSING HOME RESIDENTS WITH DEMENTIA

    May 1, 2010, 00:00

  • PSS17 IMPACT OF ADALIMUMAB ON QUALITY OF LIFE AND DEPRESSION IN PSORIASIS PATIENTS- RESULTS FROM PRIDE

    May 1, 2010, 00:00

  • PCN28 BUDGET IMPACT ANALYSIS OF NEW PROSTATE-SPECIFIC ANTIGEN ASSAY AND INDEX FOR PROSTATE CANCER DETECTION

    May 1, 2010, 00:00

  • PCN21 REAL-WORLD CLINICAL OUTCOMES OF PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER - RESULTS FROM A US LOCAL ONCOLOGY PRACTICE

    May 1, 2010, 00:00

  • PCN42 INDIRECT COST ASSOCIATED WITH BREAST CANCER TO US EMPLOYERS

    May 1, 2010, 00:00

  • PIN11 A LONGITUDINAL DATABASE STUDY OF ECONOMIC CONSEQUENCES OF CHRONIC HEPATITIS C VIRUS (HCV) INFECTIONS IN THE U.S.

    May 1, 2010, 00:00

  • PND38 SOCIODEMOGRAPHIC PATTERNS OF INSOMNIA DRUG PRESCRIPTIONS

    May 1, 2010, 00:00

  • PMH84 COST OF PHARMACEUTICAL CARE IN PATIENTS WITH METABOLIC SYNDROMES CAUSED BY ATYPICAL ANTIPSYCHOTICS

    May 1, 2010, 00:00

  • PHP7 COMPARING POTENTIAL STRATEGIES TO ELIMINATING MEDICARE PART DS COVERAGE GAP

    May 1, 2010, 00:00

  • PMS20 COST EFFECTIVENESS ANALYSIS OF MANAGING CHRONIC GOUT WITH FEBUOXSTAT (ULORIC) VERSUS ALLOPURINOL (ZYLOPRIM)

    May 1, 2010, 00:00

  • PIH19 IMPACT OF SEVERITY DIFFERENCES ON LOGICAL INCONSISTENCIES IN VALUES FOR EQ-5D HEALTH STATES

    May 1, 2010, 00:00

  • PCN26 BUDGET IMPACT ANALYSIS OF AN ORGANIZED BREAST CANCER SCREENING PROGRAM BASED ON ANNUAL MAMOGRAPHY FOR COLOMBIAN WOMEN

    May 1, 2010, 00:00

  • PMC30 AGREEMENT BETWEEN PROMIS GLOBAL HEALTH SCALE AND SF-36 SCORES AMONG SURGICAL PATIENTS

    May 1, 2010, 00:00

  • PSS11 COST-UTILITY ANALYSIS OF MAINTENANCE TREATMENT WITH TACROLIMUS OINTMENT IN ADULTS AND CHILDREN WITH MODERATE AND SEVERE ATOPIC DERMATITIS

    May 1, 2010, 00:00

  • SB3 COMPARISON OF DIFFERENT PROPENSITY SCORE MATCHING METHODS IN ELDERLY ANTIPSYCHOTIC USERS

    May 1, 2010, 00:00

  • UT1 ASSOCIATION BETWEEN UTILITY AND TREATMENT AMONG PROSTATE CANCER PATIENTS

    May 1, 2010, 00:00

  • PMC3 REVIEW OF COST EFFECTIVENESS ANALYSES THAT INCORPORATE NUMBER NEEDED TO TREAT/HARM VALUES

    May 1, 2010, 00:00

  • PCV102 HEALTH BELIEFS AND THEIR IMPACT ON MEDICATION ADHERENCE IN PATIENTS WITH COEXISTING DIABETES, DYSLIPIDEMIA AND HYPERTENSION

    May 1, 2010, 00:00

  • PMS72 A NEW METHODOLOGY TO ASSESS CLINICAL CHANGE USING CHARTS IN RHEUMATOID ARTHRITIS (RA) PATIENTS ON TNF BLOCKERS

    May 1, 2010, 00:00

  • PHP12 THE RELATIONSHIP OF RESEARCH AND DEVELOPMENT ACTIVITY WITH U.S. MEDICAL DRUG SHORTAGES

    May 1, 2010, 00:00

  • PIH12 DULOXETINE DOSING PATTERNS AND HEALTH CARE COSTS AMONG ELDERLY DIAGNOSED WITH FIBROMYALGIA

    May 1, 2010, 00:00

  • PUK25 CASE MIX ADJUSTMENT- THE CONSEQUENCES OF DIVERGENCE IN ACCESS TO DATA

    May 1, 2010, 00:00

  • PSY10 THE DIRECT MEDICAL COSTS OF PSORIASIS- EVIDENCE FROM UNITED STATES NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • PIN1 HEPATITIC-C BURDEN ASSESSMENT IN FRANCE FROM A TRANSMISSION MODEL

    May 1, 2010, 00:00

  • PCN3 RELIABILITY OF CLINICIAN VS. CLINICIAN ADVERSE SYMPTOM REPORTING

    May 1, 2010, 00:00

  • PCV118 CHARACTERIZATION OF COMMERCIALLY INSURED PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) RECEIVING PERCUTANEOUS CORONARY INTERVENTION (PCI)

    May 1, 2010, 00:00

  • PMS55 RACIAL AND ETHNIC DISPARITIES IN TOTAL HIP REPLACEMENT SURGERY

    May 1, 2010, 00:00

  • PMS43 HEALTH-RELATED QUALITY OF LIFE IN PERIOPERATIVE PAIN MANAGEMENT PATIENTS AFTER ORTHOPEDIC SURGERY(TOTAL KNEE ARTHROPLASTY AND SPINAL FUSION)

    May 1, 2010, 00:00

  • PIN26 COST EFFECTIVENESS ANALYSIS TO TREAT LATENT TUBERCULOSIS INFECTION- CAMPARING ISONIAZID, RIFAMPIN AND RIFAMPIN/PYRAZINAMIDE

    May 1, 2010, 00:00

  • PHP108 THE HEALTH ECONOMIC IMPACT OF ORAL NUTRITIONAL SUPPLEMENTS IN RESIDENTIAL CARE IN GERMANY

    May 1, 2010, 00:00

  • CV1 PERIOPERATIVE BLOOD PRESSURE CONTROL DURING CARDIAC SURGERY REDUCES HOSPITALIZATION COSTS

    May 1, 2010, 00:00

  • PHP36 ECONOMIC MODELS- MANAGED CARE DECISION MAKERS PERCEPTIONS AND USE

    May 1, 2010, 00:00

  • PDB25 THE ECONOMIC IMPACT OF WEIGHT LOSS FOR PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS (T2DM) IN THE US

    May 1, 2010, 00:00

  • PMC7 ESTIMATING TIME-PROFILED ECONOMIC BURDEN OF ILLNESS

    May 1, 2010, 00:00

  • HE4 CHARACTERIZATION OF FREQUENT HOSPITAL EMERGENCY DEPARTMENT (ED) USE BY UN- OR UNDERINSURED PERSONS

    May 1, 2010, 00:00

  • RM2 IMPACT OF ADHERENCE WITH STATIN THERAPY ON HOSPITALIZATION RISK AND MORTALITY AMONG PATIENTS WITH DIABETES

    May 1, 2010, 00:00

  • PMS23 ECONOMICAL EVALUATION OF ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00

  • PHP85 WHEN AND HOW ARE EVIDENCE REVIEWS ON PERSONALIZED MEDICINE USED FOR HEALTH PLAN POLICY DECISIONS?

    May 1, 2010, 00:00

  • PCV91 HEALTH CARE RESOURCE UTILIZATION AMONG ADULTS WITH TYPE 2 DIABETES MELLITUS, HYPERTENSION, AND OBESITY

    May 1, 2010, 00:00

  • PDB75 EFFECTS OF STATIN THERAPY ON HOSPITALIZATION AND MORTALITY IN PATIENTS WITH DIABETES- A RETROSPECTIVE COHORT STUDY

    May 1, 2010, 00:00

  • PHP2 VALIDITY OF THE ADHERENCE ESTIMATOR IN THE PREDICTION OF PERSISTENCE WITH CHRNONIC MEDICATIONS ASSESSED OVER M MONTHS

    May 1, 2010, 00:00

  • PCN107 EVALUATION OF QUALITY OF LIFE FOR ANTI-CANCER TREATMENT AMONGST KOREAN METASTATIC BREAST CANCER PATIENTS- A MULTICENTER, CROSS-SECTIONAL STUDY

    May 1, 2010, 00:00

  • PDB77 IDENTIFYING THE UNDERLYING FACTORS FOR DIABETES CARE AND ATTITUDES

    May 1, 2010, 00:00

  • PCV16 AN ASSESSMENT OF OPTIMAL LIPID VALUE ATTAINMENT AND ASSOCIATED DYSLIPIDEMIA TREATMENT PATTERNS FROM 2005 TO 2009 IN A COMMERCIALLY INSURED POPULATION

    May 1, 2010, 00:00

  • PDB14 BUDGET IMPACT ANALYSIS OF THE INTRODUCTION OF SAXAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES IN ARGENTINA

    May 1, 2010, 00:00

  • PCN73 COST-EFFECTIVENESS ANALYSIS OF MULTIMODAL SCREENING FOR OVARIAN CANCER

    May 1, 2010, 00:00

  • PIN9 COST-OF-ILLNESS OF CHRONIC HEPATITIS B INFECTION IN VIETNAM

    May 1, 2010, 00:00

  • PHP68 CONSUMERS KNOWLEDGE OF GENERIC OTCS- A PHARMACIST INTERVENTION STUDY

    May 1, 2010, 00:00

  • PHP103 WHEN ARE DIAGNOSTIC LABORATORY TESTS COST-EFFECTIVE? A SYSTEMATIC REVIEW OF COST-UTILITY ANALYSES

    May 1, 2010, 00:00

  • PND4 ESTIMATED COST SAVINGS WHEN TREATING RESTLESS LEGS SYNDROME (RLS) WITH GABAPENTIN ENACARBIL IN THE US

    May 1, 2010, 00:00

  • PDB4 PREVALENCE OF RENAL INSUFFICIENCY IN A COMMERICALLYINSURED POPULATION WITH TYPE 2 DIABETES MELLITUS ENROLLED IN A LARGE, US NATIONAL HEALTH PLAN

    May 1, 2010, 00:00

  • PMH41 THE SOCIETAL COST OF SCHIZOPHRENIA IN SWEDEN

    May 1, 2010, 00:00

  • PCN100 SIMILARITIES AND DIFFERENCES IN TREATMENT PATTERNS AND RESOURCE UTILISATION FOR MULTIPLE MYELOMA- A COMPARISON BETWEEN 4 NORDIC COUNTRIES

    May 1, 2010, 00:00

  • PHP1 MORE EFFECTIVELY ENGAGING CONSUMERS IN COMPARATIVE EFFECTIVENESS RESEARCH

    May 1, 2010, 00:00

  • PUK18 RENAL TRANSPLANTATION VS HEMODIALYSIS-COST EFFECTIVENESS ANALYSIS

    May 1, 2010, 00:00

  • CV3 EFFECT OF BIVALIRUDIN ON ECONOMIC OUTCOMES OF STEMI PATIENTS IN AN OBSERVATIONAL DATASET

    May 1, 2010, 00:00

  • SB4 DEALING WITH SELECTION BIAS IN NONLINEAR SETTINGS- A CASE OF COMPARATIVE EFFECTIVENESS OF STATIN PLUS FIBRATE COMBINATION THERAPY VERSUS STATIN MONOTHERAPY IN TYPE II DIABETES

    May 1, 2010, 00:00

  • PMC29 PATIENT PREFERENCE WEIGHTS FOR BENEFIT-RISK ANALYSIS- A STATIN CASE STUDY

    May 1, 2010, 00:00

  • PMC42 EXAMINATION OF THE DIFFERENCES IN PATIENT SATISFACTION BETWEEN FIRST VISIT AND RETURN VISITS- ANALYSIS OF A USA SELF-REPORTED SURVEY DATA

    May 1, 2010, 00:00

  • PSY6 IMPACT OF A PRIOR AUTHORIZATION FOR PREGABALIN ON HEALTH PLAN DRUG EXPENDITURES

    May 1, 2010, 00:00

  • CE2 COST-EFFECTIVENESS OF SILDENAFIL IN THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION IN MEXICAN ADULT PATIENTS

    May 1, 2010, 00:00

  • PHP77 AN EMPIRICAL INVESTIGATION OF MEDICAL LOSS RATIO

    May 1, 2010, 00:00

  • PIH33 PREDICTION OF DEPRESSION IN LATE PREGNANCY

    May 1, 2010, 00:00

  • PMS66 REAL-WORLD TRENDS IN THE DIAGNOSIS AND ASSESSMENT OF RHEUMATOID ARTHRITIS (RA) AMONG RHEUMATOLOGISTS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCN44 ASSESSMENT OF HEALTH CARE UTILIZATION AND COST AMONG METASTATIC MELANOMA PATIENTS IN A US MANAGED CARE POPULATION

    May 1, 2010, 00:00

  • PIH6 PREVALENCE AND PREDICTORS OF POLYPHARMACY AMONGST ELDERLY PATIENTS- A POPULATION-BASED COHORT STUDY

    May 1, 2010, 00:00

  • SB1 EXPENDITURE OF DISEASE MODIFYING ANTI-RHEUMATOID TREATMENT-LAGGED TREATMENTS AS INSTRUMENTAL VARIABLES IN PANEL DATA

    May 1, 2010, 00:00

  • PHP93 ASSESSMENT OF METABOLIC MONITORING OF PATIENTS PRESCRIBED SECOND GENERATION ANTIPSYCHOTICS (SGAS) USING ELECTRONIC MEDICAL RECORD (EMR) DATA

    May 1, 2010, 00:00

  • PRS14 THE IMPACT OF ASTHMA ON HEALTH CARE UTILIZATION AND EXPENDITURE OF PEDIATRIC PATIENTS

    May 1, 2010, 00:00

  • PMC22 THE IMPACT OF A HOST COUNTRYS CULTURE ON IMMIGRANT LANGUAGE

    May 1, 2010, 00:00

  • PSY3 CENTRAL VENOUS LINE INFECTIONS IN PATIENTS WITH HEMOPHILIA AND HOME CARE SERVICES

    May 1, 2010, 00:00

  • PDB54 CLINICAL AND ECONOMIC OUTCOMES OF A DIABETES MEDICATION MANAGEMENT PROGRAM

    May 1, 2010, 00:00

  • PMS63 EVALUATION OF THE QUALITY AND CONTENT OF OSTEOPOROSIS PATIENT EDUCATION INFORMATION AVAILABLE ON THE INTERNET

    May 1, 2010, 00:00

  • PMC15 SYNCHRONIZATION OF RANDOM NUMBER STREAMS GREATLY ENHANCES EFFICIENCY OF PROBABILISTIC MODELS

    May 1, 2010, 00:00

  • PDB37 THE IMPACT OF DIABETES ON WORKPLACE ABSENTEEISM AND PRESENTEEISM- A COMPARISON OF CHINA AND JAPAN

    May 1, 2010, 00:00

  • ME4 THE IMPACT OF MEDICARE PART D ON HEALTH CARE UTILIZATION AND HEALTH OF THE MEDICARE BENEFICIARIES

    May 1, 2010, 00:00

  • PSY9 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE- EVIDENCE FROM UNITED STATES NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • PSY15 STUDY OF FREQUENCY OF USE AND COSTS OF PATIENTS WITH CHRONIC PAIN AND NEUROPATHIC PAIN IN COLOMBIA FROM THIRD PARTY PAYERS PERSPECTIVE

    May 1, 2010, 00:00

  • PDB67 ECONOMIC EVALUATION OF TYPE 2 DIABETES - IMPACT OF PRICING AND REIMBURSEMENT REFORMS

    May 1, 2010, 00:00

  • PIN48 USE OF AN ELECTRONIC HEALTH RECORD (EHR) DATABASE TO IDENTIFY HOSPITAL-ACQUIRED PNEUMONIA (HAP)

    May 1, 2010, 00:00

  • PCV36 CARDIOVASCULAR RISK FACTORS AMONG HISPANIC AND NONHISPANIC WHITE ADULTS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCN118 USING DISCRETE CHOICE EXPERIMENTS TO ESTIMATE THE MARGINAL WILLINGNESS TO PAY OF INSURANCE PREMIUM FOR STOMACH CANCER TREATMENT IN KOREA

    May 1, 2010, 00:00

  • PUK6 FIVE-YEAR BUDGET IMPACT ANALYSIS OF ONCE-DAILY VERSUS TWICE-DAILY TACROLIMUS, IN PATIENTS UNDERGOING RENAL TRANSPLANT IN THE UNITED KINGDOM

    May 1, 2010, 00:00

  • PCV47 ECONOMIC EVALUATION ON THE USE OF LEVOSIMENDAN IN PATIENTS WITH ACCUTE HEART FAILURE (AHF) IN THE MEXICAN CONTEXT

    May 1, 2010, 00:00

  • PCV147 NOVEL QUALITY ASSURANCE ANALYSIS REVEALS PREVIOUSLY UNDETECTED DEFICIENCIES IN A POINT OF CARE DEVICE THAT MEASURES THE INTERNATIONAL NORMALIZED RATIO

    May 1, 2010, 00:00

  • PHP87 DECISION CRITERIA FOR TECHNOLOGY ACQUISITION IN RADIOONCOLOGY-WHAT REALLY MATTERS?

    May 1, 2010, 00:00

  • PMH9 PATIENTS BENEFITS PREDICT SUBSEQUENT RESPONSE IN THE TREATMENT OF SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PGI2 ADVERSE EVENTS OF PROMETHAZINE AND ONDANSETRON IN YOUNG CHILDREN AND WOMEN OF CHILD-BEARING AGE- A PHARMACOVIGILANCE STUDY BASED ON THE FDA ADVERSE EVENT REPORTING SYSTEM

    May 1, 2010, 00:00

  • PIH5 DIAGNOSIS AND TREATMENT OF WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER AND DEPRESSION/ANXIETY

    May 1, 2010, 00:00

  • PCV87 COST-EFFECTIVENESS OF PROTON PUMP INHIBITORS FOR PREVENTION OF GASTROINTESTINAL ADVERSE EVENTS WHEN USING ASPIRIN FOR PRIMARY CARDIOVASCULAR PREVENTION

    May 1, 2010, 00:00

  • PCV150 UTILIZATION OF SECONDARY PREVENTIVE MEDICATIONS FOLLOWING ACUTE MYOCARDIAL INFARCTION (AMI)- A RETROSPECTIVE COHORT ANALYSIS OF A MEDICAID POPULATION

    May 1, 2010, 00:00

  • PSS2 RETURN ON INVESTMENT OF ABLATIVE FRACTIONAL LASERS

    May 1, 2010, 00:00

  • PMH26 A COMPARISON OF TRANSITIONS BETWEEN HEALTH STATES AND INSTITUTIONALIZATION AMONG ALZHEIMERS DISEASE DEMENTIA PATIENTS USING THE NACC-UDS DATABASE

    May 1, 2010, 00:00

  • PND15 ECONOMICAL EVALUATION OF DIFFERENT FORMS OF BETAHISTINE IN PATIENTS WITH VERTIGO

    May 1, 2010, 00:00

  • PND18 HEALTH STATUS, RESOURCE UTILIZATION, AND WORK PRODUCTIVITY FOR CAREGIVERS OF ADULTS WITH EPILEPSY- A PROPENSITY SCORE ANALYSIS OF NATIONAL SURVEY DATA

    May 1, 2010, 00:00

  • PGI22 EVALUATION OF COST-EFFECTIVENESS OF CHRONIC HEPATITIS B TREATMENTS- ENTECAVIR AND TELBIVUDINE

    May 1, 2010, 00:00

  • PCV136 PRIORITY-SETTING FOR COMPARATIVE EFFECTIVENESS RESEARCH

    May 1, 2010, 00:00

  • PND37 PROJECTING THE BURDEN OF ALZHEIMERS DISEASE IN THE UNITED STATES

    May 1, 2010, 00:00

  • PHP64 MORTALITY RATE COMPARISON BETWEEN STATES WITH AND WITHOUT PRESCRIPTION DRUG MONITORING PROGRAMS AND ASSOCIATED FEDERAL COSTS

    May 1, 2010, 00:00

  • PCV137 ANALYSIS OF HEALTH CARE OUTCOME FOR CONGESTIVE HEART FAILURE (CHF) PATIENTS

    May 1, 2010, 00:00

  • PND2 THE VALUE OF A PREDICTIVE DIAGNOSTIC BLOOD TEST IN MULTIPLE SCLEROSIS (MS)

    May 1, 2010, 00:00

  • PCV157 ACCOUNTING FOR TRIAL-EXCLUDED MEDICAL CONDITIONS WHEN SIMULATING MORTALTIY IN CLINICAL TRIAL POPULATIONS

    May 1, 2010, 00:00

  • PHP22 UTILIZATION OF PRESCRIBED PAIN MEDICATIONS PRIOR TO THE INITIATION OF DULOXETINE THERAPY

    May 1, 2010, 00:00

  • HE1 COST-EFFECTIVENESS OF 1ST LINE CHEMOTHERAPY REGIMENS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER AMONG PATIENTS RECEIVING CARE IN THE OUTPATIENT COMMUNITY SETTING

    May 1, 2010, 00:00

  • PCN127 EFFECT OF ACCESS TO CANCER CARE ON AGE-SPECIFIC UTILIZATION OF CHEMOTHERAPY AMONG ELDERLY WOMEN WITH METASTATIC BREAST CANCER

    May 1, 2010, 00:00

  • PMH69 THE EFFECT OF A TELEPHONIC PATIENT SUPPORT PROGRAM ON TREATMENT OUTCOMES AMONG A SAMPLE OF OPIOID DEPENDNCE PATIENTS- ONE YEAR FOLLOW-UP

    May 1, 2010, 00:00

  • PCV126 THE CARDIOVASCULAR CONSEQUENCES OF SWITCHING FROM ATORVASTATIN TO GENERIC SIMVASTATIN IN THE NETHERLANDS

    May 1, 2010, 00:00

  • PCV60 SYSTEMATIC REVIEW OF THE ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM TREATMENT

    May 1, 2010, 00:00

  • PCN64 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE (BSC) IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC)- THE PUBLIC HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL

    May 1, 2010, 00:00

  • PCN34 ECONOMIC BURDEN OF MYELODYSPLASTIC SYNDROMES AMONG US MEDICARE BENEFICIARIES- INCREASED COSTS IN TRANSFUSION DEPENDENT PATIENTS

    May 1, 2010, 00:00

  • UT2 COMPARISON OF HEALTH STATE UTILITY ESTIMATES IN COST-EFFECTIVENESS ANALYSIS

    May 1, 2010, 00:00

  • PCV3 ESTIMATION OF ADVERSE EVENTS RELATED WITH MEDICARE PATIENTS WHO UNDERWENT HIP FRACTURE SURGERY AND SUFFERED VENOUS THROMBOEMBOLISM VERSUS NO VENOUS THROMBOEMBOLISM

    May 1, 2010, 00:00

  • PCV27 THE USE OF ALENDRONATE AND CARDIOVASCULAR DISEASES

    May 1, 2010, 00:00

  • PSY14 COMPARISON OF ABSENTEEISM AND TOTAL HEALTH CARE EXPENDITURES FOR INFLAMMATORY BOWEL DISEASE PRE AND POST ANTI-TNF USE

    May 1, 2010, 00:00

  • PCV125 UTILIZATION PATTERNS FOR ANTIARRHYTHMIC DRUGS IN BIG 5 EU MARKETS- TEMPORAL ANALYSIS FROM 2005 TO 2009

    May 1, 2010, 00:00

  • PCN37 BURDEN OF INPATIENT CASES OF ACUTE EXACERBATIONS OF COPD WITH LUNG CANCER IN THE UNITED STATES IN 2006

    May 1, 2010, 00:00

  • PDB20 AN ANALYSIS OF DIFFERENCES IN COST QUARTILES FOR PATIENTS WITH TYPE 2 DIABETES IN A LARGE CLAIMS DATABASE WITH LINKED LABORATORY RESULTS

    May 1, 2010, 00:00

  • PDB49 AGE-SPECIFIC ORIGINALS- USING THE PEDIATRIC QUALITY OF LIFE) DIABETES MODULE TO STUDY SIMILARITIES AND DIFFERENCES IN TARGET LANGUAGES

    May 1, 2010, 00:00

  • PMH80 THE ASSOCIATION BETWEEN TYPE OF ANTIPSYCHOTIC AND RATES OF HOSPITALIZATION AMONG MEDICARE BENEFICIARIES

    May 1, 2010, 00:00

  • PMH16 THE COMPARATIVE EFFICACY AND SAFETY OF ADJUNCTIVE ANTIPSYCHOTICS IN MAJOR DEPRESSIVE DISORDER PATIENTS THAT FAILED TO RESPOND TO CONVENTIONAL ANTIDEPRESSANTS

    May 1, 2010, 00:00

  • PCV13 THE UTILISATION AND EFFECTIVENESS OF ANTITHROMBOTIC AGENTS FOR PREVENTING DEEP VEIN THROMBOSIS AFTER TOTAL HIP REPLACEMENT-A CASE STUDY IN SOUTHERN TAIWAN

    May 1, 2010, 00:00

  • PCN144 COMPARITIVE KNOWLEDGE OF BREAST SELF EXAMINATION IN MIDWIFERY AND NURSING STUDENTS IN ISLAMIC AZAD UNIVERSITY KARAJ BRANCH

    May 1, 2010, 00:00

  • PIH25 PSYCHOMETRIC PROPERTIES OF THE OXFORD WORRIES ABOUT LABOUR SCALE (OWLS)

    May 1, 2010, 00:00

  • PCV90 COST-EFFECTIVENESS OF ATORVASTATIN IN ACUTE CORONARY SYNDROME PATIENTS IN SWEDEN

    May 1, 2010, 00:00

  • PDB57 IMPROVING CLINICAL OUTCOMES FOR EMPLOYEES PARTICIPATING IN A PHARMACIST PROVIDED MTM

    May 1, 2010, 00:00

  • PCN121 USING DISCRETE CHOICE EXPERIMENTS TO ESTIMATE THE MARGINAL WILLINGNESS TO PAY OF INSURANCE PREMIUM FOR LIVER CANCER TREATMENT IN KOREA

    May 1, 2010, 00:00

  • PCN2 DIABETIC MEDICATIONS AND ITS ASSOCIATION WITH MORTALITY IN HOSPITALIZED CANCER PATIENTS

    May 1, 2010, 00:00

  • PND9 HEALTH CARE COSTS STRATIFIED BY EPILEPSY SEVERITY IN A US COMMERCIALLY INSURED SETTING

    May 1, 2010, 00:00

  • PCN157 METHODOLOGIC ISSUES OF IDENTIFYING FEBRILE NEUTROPENIA PATIENTS USING MEDICAL CLAIM DATA

    May 1, 2010, 00:00

  • PMS39 ACUPUNCTURE OR PHYSICAL THERAPY? LOW-BACK PAIN PATIENTS CHOICE-A QUALITATIVE STUDY IN A GENERAL HOSPITAL, CHINA

    May 1, 2010, 00:00

  • PCN16 CANCER INCIDENCE IS INFLUENCED BY INSULIN DOSE AND METFORMIN IN TYPE 2 DIABETES

    May 1, 2010, 00:00

  • PCN117 QUALITY OF LIFE SCALE FOR PATIENTS WITH HAND-FOOT SYNDROME - FIRST RESULTS

    May 1, 2010, 00:00

  • PMH54 ECONOMIC EVALUATION OF ESCITALOPRAM TO TREAT MAJOR DEPRESSIVE DISORDER

    May 1, 2010, 00:00

  • PDB19 COMPLICATIONS OF TYPE II DIABETES AND THEIR COST

    May 1, 2010, 00:00

  • PSY45 IMPACT OF ACUTE BLEEDING AND ADMINISTRATION OF BYPASSING AGENTS (BPA) ON DAILY ACTIVITIES OF PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR CAREGIVERS AND FAMILIES- OBSERVATIONS FROM THE DOSING OBSERVATIONAL STUD ...

    May 1, 2010, 00:00

  • PIN49 APPLICATION OF A NATIONAL PRESCRIPTION DATABASE TO DEVISE A PREDICTIVE MODEL FOR TAILORING HIV/AIDS THERAPEUTIC MANAGEMENT

    May 1, 2010, 00:00

  • PMC27 HARMONISATION AS PART OF THE TRANSLATION AND LINGUISTIC PROCESS- WHAT IS THE OPTIMAL METHOD?

    May 1, 2010, 00:00

  • PHP31 COMPUTERIZED INTERVENTIONS TO OBTAIN INDICATION INFORMATION FOR INPATIENT PRESCRIPTIONS- A PILOT STUDY IN DRUGS FREQUENTLY USED OFF-LABEL

    May 1, 2010, 00:00

  • PIN37 COST EFFECTIVENESS ANALYSES (CEA) OF LOPINAVIR/RITONAVIR (LPV/R) AND ATAZANAVIR PLUS RITONAVIR (ATV VE HIV-I INFECTED PATIENTS BASED ON CASTLE 48-WEEK STUDY- APPLICATION TO GERMANY, ITALY, SPAIN, AND THE UNITED KINGDOM

    May 1, 2010, 00:00

  • PCN8 IMPACT OF 5-HT3-RECEPTOR ANTAGONIST STEP THERAPY ON CHEMOTHERAPY INDUCED NAUSEA AND VOMITING ASSOCIATED HOSPITAL AND EMERGENCY ROOM EVENTS

    May 1, 2010, 00:00

  • PGI13 THE DISEASE BURDEN OF IRRITABLE BOWEL SYNDROME IN KOREA

    May 1, 2010, 00:00

  • CN4 USING QALYS IN CANCER- WHAT ARE THE METHODOLOGICAL LIMITATIONS?

    May 1, 2010, 00:00

  • PUK4 EFFECT OF ATYPICAL ANTIPSYCHOTICS ON URINARY INCONTINENCE IN US NURSING HOME RESIDENTS USING PSYCHOTROPIC MEDICATIONS

    May 1, 2010, 00:00

  • PCN98 COST-EFFECTIVENESS OF ADJUVANT THERAPY WITH TRASTUZUMAB IN THE TREATMENT OF EARLY BREAST CANCER (EBC) IN ROMANIA

    May 1, 2010, 00:00

  • PCN11 ASSESSING THE TREATMENT EFFECT OF RASBURICASE ALONE VERSUS RASBURICASE AND ALLOPURINOL COMBINATION THERAPY USING PROPENSITY SCORES

    May 1, 2010, 00:00

  • PGI16 PATTERNS OF LUBIPROSTONE UTILIZATION AND COSTS IN MEMBERS OF A LARGE HEALTH BENEFITS COMPANY

    May 1, 2010, 00:00

  • PMC48 METHODS FOR IDENTIFYING CASE REPORTS OF SUSPECTED ADVERSE DRUG REACTIONS- AN EVALUATION OF THE EFFICIENCY OF ALTERNATIVE SEARCH STRATEGIES IN MEDLINE AND EMBASE

    May 1, 2010, 00:00

  • PCV114 HEALTH-RELATED QUALITY OF LIFE AMONG WOMEN WITH CORONARY ARTERY DISEASE TREATED WITH PSYCHOTROPIC MEDICATIONS

    May 1, 2010, 00:00

  • PCN142 EVALUATING COMPARATIVE EFFECTIVENESS RESEARCH FOR ONCOLOGY IN THE US- AN ANALYSIS BASED ON LESSONS FROM HEALTH TECHNOLOGY ASSESSMENTS IN EUROPE

    May 1, 2010, 00:00

  • PCV37 VENOUS THROMBOEMBOLISM IN THE SINGAPOREAN POPULATION- THE NEED TO REVISIT RISK ASSESSMENT TOOLS FOR PROPHYLAXIS

    May 1, 2010, 00:00

  • PIN13 IMPACT ON COST OF INAPPROPRIATE INITIAL EMPIRICAL USE OF ANTIBIOTIC IN PATIENTS WITH COMPLICATED INFECTIONS FROM TWO LARGE BRAZILIAN HOSPITALS

    May 1, 2010, 00:00

  • PMC45 INTEGRATED INTERPRETATION OF KAPPA WITH SENSITIVITY AND SPECIFICITY

    May 1, 2010, 00:00

  • PMS52 BISPHOSPHONATE THERAPY IN OSTEOPOROSIS- AN ANALYSIS FOCUSING ON DRUG CLAIMS BY SENIORS 2001 TO 2007

    May 1, 2010, 00:00

  • PMH93 AGREEMENT BETWEEN PATIENTS WITH MILD DEMENTIA AND CAREGIVERS ON THE PROMIS CAT MEASURE OF PERCEIVED COGNITIVE FUNCTION

    May 1, 2010, 00:00

  • PRS26 COST-UTILITY ANALYSIS OF TIOTROPIUM, MEDICINE FOR CHRONIC OBSTRACTIVE PULMONARY DISEASES (COPD), IN JAPAN

    May 1, 2010, 00:00

  • PDB28 COST-EFFECTIVENESS OF SOMASTATIN ANALOGUES FOR THE TREATMENT OF ACROMEGALY IN COLOMBIA

    May 1, 2010, 00:00

  • PMC14 MEDICATION LABEL EVALUATION PROCESS MODEL- USING THE STRUCTURAL EQUATION MODELING APPROACH TO BETTER PREDICT PURCHASE INTENTION

    May 1, 2010, 00:00

  • PGI4 SYSTEMATIC REVIEW AND META-ANALYSIS OF PUBLISHED RANDOMIZED CONTROLLED TRIALS COMPARING THE EFFICACY OF PEGINTERFERON-ALPHA-2A VERSUS PEGINTERFERON ALPHA-2B BOTH PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS

    May 1, 2010, 00:00

  • PHP97 MEDICATION THERAPY QUALITY- A REVIEW OF MEASURES AND CONCEPTUAL FRAMEWORK TO ALIGN PHYSICIANS AND PHARMACISTS

    May 1, 2010, 00:00

  • PHP101 DIFFERENCES IN CLINICIAN REPORTED EASE OF USE BETWEEN 2 HEMOSTASIS TREATMENT METHODS- RESULTS FROM A RANDOMIZED CONTROLLED STUDY

    May 1, 2010, 00:00

  • TR3 TIME-RELEASE LAUNCH IN RELATION TO GENERIC LAUNCH- CASES

    May 1, 2010, 00:00

  • CE3 COST-EFFECTIVENESS OF POLYMYXIN B IMMOBILIZED FIBER COLUMN AND CONVENTIONAL MEDICAL THERAPY IN THE MANAGEMENT OF SEVERE ABDOMINAL SEPSIS IN ITALY

    May 1, 2010, 00:00

  • PIN34 COST MINIMIZATION ANALYSIS OF THREE CANDIDA IDENTIFICATION TESTS WITH PREDICTION MODELS BASED ON REAL-WORLD DATA

    May 1, 2010, 00:00

  • PMH42 ECONOMIC COSTS OF ABUSE AND MISUSE OF PRESCRIPTION OPIOIDS

    May 1, 2010, 00:00

  • DB2 EVALUATION OF AGREEMENT BETWEEN INTERNET-BASED SELF- AND PROXY-REPORTED HEALTH CARE UTILIZATION AND ADMINISTRATIVE HEALTH CARE CLAIMS

    May 1, 2010, 00:00

  • PRS44 ANTIBIOTIC PRESCRIBING FOR ACUTE RESPIRATORY TRACT INFECTIONS IN ADULT PRIMARY CARE- IS GOOD INSURANCE BAD FOR ANTIBIOTIC PRESCRIBING?

    May 1, 2010, 00:00

  • PCV15 BLOOD PRESSURE GOAL ACHIEVEMENT AMONG HYPERTENSION PATIENTS TREATED WITH VALSARTAN-BASED SINGLE PILL COMBINATION VS. ARB-BASED FREE COMBINATION IN SOUTH CENTRAL REGION

    May 1, 2010, 00:00

  • PDB10 SURVIVAL AS A FUNCTION OF HBA1C IN PEOPLE WITH TYPE 2 DIABETES- A RETROSPECTIVE COHORT STUDY

    May 1, 2010, 00:00

  • PIH20 THE PSYCHOMETRIC PROPERTIES OF THE PERCEPTIONS OF CARE ADJECTIVE CHECK LIST-REVISED (PCACL-R) EVALUATED IN A LARGE UK MATERNITY CARE POPULATION

    May 1, 2010, 00:00

  • PIN44 UNINFECTED CHILDREN OF HIV-INFECTED AND UNINFECTED PARENT(S)- A COMPARATIVE ANALYSIS OF HEALTH CARE UTILIZATION AND HEALTH STATUS

    May 1, 2010, 00:00

  • PMH6 NURSING HOME USE OF ATYPICAL ANTIPSYCHOTICS FOR BEHAVIORAL AND PSYCHOLOGICAL PROBLEMS OF ELDERLY WITH DEMENTIA- A SYSTEMATIC REVIEW

    May 1, 2010, 00:00

  • PHP89 THE INFLUENCE OF SAFETY ISSUES ON DECISIONS OF CONSULTATIVE COUNCIL OF THE AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND

    May 1, 2010, 00:00

  • PIN38 COSTS OF RECRUITING PATIENTS WITH HIV INTO A RANDOMIZED CLINICAL TRIAL OF BEHAVIORAL INTERVENTIONS FOR ANTIRETROVIRAL MEDICATION ADHERENCE

    May 1, 2010, 00:00

  • HE3 CAN INNOVATION BE REWARDED WITH THE APPLICATION OF RIGID COST-EFFECTIVENESS THRESHOLDS? THE HER2VE BREAST CANCER CASE STUDY

    May 1, 2010, 00:00

  • PCV120 IMPACT OF THE MEDICARE PART D DONUT-HOLE ON PATIENTS WITH HYPERTENSION OR HYPERLIPIDEMIA

    May 1, 2010, 00:00

  • PCN33 OPEN VERSUS LAPAROSCOPIC PROCEDURES FOR COLECTOMY SURGERY FOR PATIENTS WITH COLON RECTAL CANCER- AN ANALYSIS OF OPPORTUNITY COSTS, UNDER THE PERSPECTIVE OF A PRIVATE HOSPITAL IN BRAZIL

    May 1, 2010, 00:00

  • PSY28 COST-EFFECTIVENESS ANALYSIS OF CELECOXIB FOR THE MANAGEMENT OF LOW BACK PAIN AT THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2010, 00:00

  • PMH5 INFLUENCE OF PSYCHIATRIC COMORBIDITY AND POLYPHARMACY ON HOSPITALIZATION AND EXPENDITURES AMONG SECOND GENERATION ANTIPSYCHOTIC USERS WITH METABOLIC SYNDROME

    May 1, 2010, 00:00

  • PMH87 NATIONAL TRENDS IN PRESCRIBING ANTIDEPRESSANTS FOR DEPRESSION-BEFORE AND AFTER FDA ADVISORY ON RISK OF SUICIDALITY AMONG CHILDREN AND ADOLESCENTS

    May 1, 2010, 00:00

  • PHP23 A TREND ANALYSIS OF DISCONTINUED NEW MOLECULAR ENTITIES IN THE US

    May 1, 2010, 00:00

  • PIH32 HEALTH CARE ACCESS AND UTILIZATION AMONG UNITED STATES ADULTS BY CENSUS REGIONS

    May 1, 2010, 00:00

  • PCV95 PREDICTIVE MODELS TO IDENTIFY NON-ADHERENCE TO DYSLIPIDEMIC MEDICATIONS USING PHARMACY AND MEDICAL CLAIMS DATA FROM A COMMERCIAL HEALTH PLAN

    May 1, 2010, 00:00

  • PMH76 FUNCTIONAL IMPAIRMENT IN CHILDREN AND ADOLESCENTS WITH DEPRESSION

    May 1, 2010, 00:00

  • PMC2 REVIEW OF PHARMACOECONOMIC RECOMMENDATIONS FOR THE DEFINITION OF A SOCIETAL PERSPECTIVE

    May 1, 2010, 00:00

  • PMH46 TREATMENT PERSISTENCE WITH DULOXETINE AND HEALTH CARE COSTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

    May 1, 2010, 00:00

  • PMS47 UNDERUSE OF BMD MEASUREMENTS AND BISPHOSPHONATE TREATMENT IN WOMAN OVER AGE 50 WITH OSTEOPOROSIS IN A NATIONALLY-REPRESENTATIVE EMR DATABASE

    May 1, 2010, 00:00

  • PCV49 COMPARATIVE EFFECTIVENESS OF LOW-MOLECULAR-WEIGHTHEPARINS- META-ANALYSIS AND PHARMACOECONOMIC ASSAY

    May 1, 2010, 00:00

  • PMH8 IMPROVED TREATMENT OUTCOMES FOLLOWING A SWITCH FROM RISPERIDONE TO OLANZAPINE IN A 1-YEAR NATURALISTIC STUDY OF SCHIZOPHRENIA PATIENTS IN JAPAN

    May 1, 2010, 00:00

  • PSY5 A META-ANALYSIS OF EFFICACY AND SAFETY OF PARECOXIB IN ORTHOPEDICS SURGERY

    May 1, 2010, 00:00

  • PND3 GASTROINTESTINAL DISORDERS IN PATIENTS WITH PARKINSONS DISEASE- A DOUBLE-EDGED SWORD

    May 1, 2010, 00:00

  • PCV104 AN ASSESSMENT OF ADHERENCE TO SINGLE-PILL VERSUS MULTI-PILL COMBINATION LIPID-MODIFYING THERAPIES AMONG PATIENTS WITH MIXED DYSLIPIDEMIA IN A MANAGED CARE POPULATION

    May 1, 2010, 00:00

  • PND26 VALIDATING USE OF THE MIGRAINE-SPECIFIC QUALITY OF LIFE QUESTIONNAIRE VERSION 2.1 (MSQ) ACROSS MIGRAINE DISORDERS

    May 1, 2010, 00:00

  • PCN159 HFS 14- A SPECIFIC QUALITY OF LIFE SCALE FOR PATIENTS WITH HAND-FOOT SYNDROME

    May 1, 2010, 00:00

  • PCN59 THE POTENTIAL ECONOMIC BENEFITS PROVIDED BY COMBINING CISPLATIN WITH SRC INHIBITOR KX1-004 FOR CANCER REGIMENS

    May 1, 2010, 00:00

  • PHP112 TRANSPLANT IMMUNOSUPPRESSIVE DRUG EXPENDITURE BY U.S. MEDICAID PROGRAMS AND UTILIZATION AMONG BENEFICIARIES- A TREND ANALYSIS FROM 1991 TO 2007

    May 1, 2010, 00:00

  • PCV135 TREATMENT PATTERNS IN ATRIAL FIBRILLATION- AGENTS USED IN CURRENT PATIENT MANAGEMENT

    May 1, 2010, 00:00

  • PHP69 CMS VS. NICE COVERAGE OF TECHNOLOGIES- HOW DO THEY COMPARE?

    May 1, 2010, 00:00

  • PDB53 IMPACT OF HYPOGLYCAEMIA ON PATIENT REPORTED OUTCOMES- A SYSTEMATIC LITERATURE REVIEW

    May 1, 2010, 00:00

  • PSY7 ECONOMIC VALUE OF LIDOCAINE PATCH 5 VS. GABAPENTIN OR PREGABALIN IN MEDICAID PATIENTS WITH POST HERPETIC NEURALGIA

    May 1, 2010, 00:00

  • PMS54 RACIAL AND ETHNIC DISPARITIES IN TOTAL KNEE REPLACEMENT SURGERY

    May 1, 2010, 00:00

  • PIN50 METHODS TO IDENTIFY AND COMPARE BLOODSTREAM INFECTION RATES AMONG PATIENTS ADMINISTERED PARENTERAL NUTRITION VIA HOSPITAL COMPOUNDED VS. PREMIXED MULTI-CHAMBER BAGS

    May 1, 2010, 00:00

  • PHP111 IMPACT OF BLEEDING-RELATED COMPLICATIONS AND BLOOD PRODUCT TRANSFUSIONS ON HOSPITAL LENGTH OF STAY AND COSTS IN INPATIENT SURGICAL PATIENTS

    May 1, 2010, 00:00

  • UT3 RELIABILITY OF HEALTH UTILITIES INDEX (HUI) SCORES- PATIENT AND PARENT INTER-RATER AGREEMENT ACROSS TWO CLINICAL TRIALS OF TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) IN CHILDHOOD

    May 1, 2010, 00:00

  • PMS38 PREFERENCES AND WILLINGNESS TO PAY FOR OSTEOARTHRITIS TREATMENTS AMONG THE MEDICARE POPULATION

    May 1, 2010, 00:00

  • PIH13 HEALTH CARE UTILIZATION AND COSTS FOR THE TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER

    May 1, 2010, 00:00

  • PND27 CONFIRMATORY FACTOR ANALYSIS AND DIFFERENTIAL ITEM FUNCTIONING ANALYSIS OF THE MIGRAINE-SPECIFIC QUALITY OF LIFE QUESTIONNAIRE VERSION 2.1 IN CHRONIC MIGRAINEURS

    May 1, 2010, 00:00

  • PCV154 USING DIFFERENT MEASURES TO DETERMINE TIME IN THERAPEUTIC INR RANGE AMONG WARFARIN-TREATED PATIENTS FOLLOWING TOTAL HIP OR KNEE REPLACEMENT

    May 1, 2010, 00:00

  • PCV98 ADHERENCE TO LIPID LOWERING THERAPIES AS A PREDICTOR OF CHOLESTEROL OUTCOMES- A LITERATURE REVIEW

    May 1, 2010, 00:00

  • PHP96 TRENDS IN PREVENTABLE HOSPITALIZATION PATTERNS IN THE US- EXAMINING SMALL AREA VARIATION IN PRIMARY CARE PERFORMANCE IN THE LAST DECADE

    May 1, 2010, 00:00

  • PGI6 TEMPORAL CHANGES IN SURGICAL PROCEDURES FOR MANAGEMENT OF DIVERTICULAR DISEASE

    May 1, 2010, 00:00

  • PCN55 COSTS ASSOCIATED TO THE TREATMENT OF DIFFERENT STAGES OF MEXICAN PATIENTS WITH NON-HODGKIN LYMPHOMA

    May 1, 2010, 00:00

  • PMS25 A PHARMACOECONOMIC REVIEW OF ECONOMIC ANALYSES OF BIOLOGIC THERAPIES IN PATIENTS WITH ANKYLOSING SPONDILITIS

    May 1, 2010, 00:00

  • PCN43 INITIAL COSTS OF TREATMENT AMONG STAGE IV PROSTATE CANCER (PCA) CHEMOTHERAPY PATIENTS IN SEER-MEDICARE

    May 1, 2010, 00:00

  • PSY17 LITERATURE REVIEW OF THE ECONOMIC BURDEN OF IRON OVERLOAD ASSOCIATED WITH -THALASSEMIA, SICKLE CELL DISEASE, AND MYELODYSPLASTIC SYNDROMES IN THE UNITED STATES (US)

    May 1, 2010, 00:00

  • PIH26 HEALTH RELATED QUALITY OF LIFE AMONG PARENTS WITH CHILDREN DIAGNOSED WITH A NEURO-DEVELOPMENTAL DISORDER

    May 1, 2010, 00:00

  • PRS34 EVALUATING PEOPLES PREFERENCES FOR PREVENTIVE TREATMENT OF LATENT TUBERCULOSIS INFECTION USING A DISCRETE CHOICE EXPERIMENT

    May 1, 2010, 00:00

  • HT4 PRAGMATIC CLINICAL TRIALS FOR DRUG APPROVAL- IS IT REALISTIC?

    May 1, 2010, 00:00

  • PMH51 THE COST-EFFECTIVENESS OF EARLY RESPONDERS VERSUS EARLY NON-RESPONDERS TO ATYPICAL ANTIPSYCHOTIC THERAPY

    May 1, 2010, 00:00

  • PRS48 ASSESSING THE TIME-DEPENDENT NATURE OF COMORBIDITY INFLUENCE IN COPD

    May 1, 2010, 00:00

  • PUK23 ADHERENCE TO A GUIDELINE FOR ERYTHROPOIESIS STIMULATING AGENTS IN CHRONIC KIDNEY DISEASE

    May 1, 2010, 00:00

  • PMH36 ESTIMATED UNITED STATES INCIDENCE AND COST OF EMERGENCY DEPARTMENT STAFF ASSAULTS PERPETRATED BY AGITATED ADULT PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER

    May 1, 2010, 00:00

  • PDB61 RACIAL AND ETHNIC DISPARITIES IN QUALITY OF HEALTH CARE AMONG ADULTS WITH DIABETES IN THE UNITED STATES IN 2005 AND 2006

    May 1, 2010, 00:00

  • PMH73 EVALUATION OF PSYCHOMETRIC EQUIVALENCE BETWEEN INTERACTIVE VOICE-RESPONSE (IVR) AND PAPER VERSIONS OF DAILY ASSESSMENT SCALE FOR ANXIETY (DAS-A)

    May 1, 2010, 00:00

  • PDB30 COST-EFFECTIVENESS ANALYSIS OF THE DIABETES MEDICATIONS IN MEDICARE WITH SAS

    May 1, 2010, 00:00

  • PSY52 URBAN GREEN SPACE AND PARK EXPENDITURES AS PREDICTORS OF URBAN OBESITY

    May 1, 2010, 00:00

  • PDB5 GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30

    May 1, 2010, 00:00

  • PCV129 INCREMENTAL HEALTH CARE EXPENDITURE AND RESOURCE UTILIZAION DUE TO CARDIOVASCULAR DISEASE AMONG PATIENS WITH CHRONIC OBSTRUCTIVE DISORDER IN THE HOSPITAL SETTING

    May 1, 2010, 00:00

  • PIH1 THE NATIONAL BURDEN OF PEDIATRIC ADVERSE DRUG EVENTS- A CASE-CONTROL STUDY USING THE 2006 KIDS INPATIENT DATABASE

    May 1, 2010, 00:00

  • PCN9 USING PROPENSITY SCORES TO REDUCE SELECTION BIAS IN AN OBSERVATIONAL STUDY COMPARING RASBURICASE TO ALLOPURINOL IN THE US

    May 1, 2010, 00:00

  • PRS36 NEED FOR IMPROVING ACCESS TO ESSENTIAL MEDICINES AND TREATMENT BEHAVIOUR TO BRONCHIAL ASTHMA A CHRONIC DISEASE

    May 1, 2010, 00:00

  • PND22 MAPPING FROM DISEASE-SPECIFIC MEASURES TO HEALTH-STATE UTILITY VALUES IN CHRONIC MIGRAINEURS

    May 1, 2010, 00:00

  • PMH44 IMPACT OF ALTERNATIVE DEFINITIONS OF MEDICATION COMPLIANCE ON TREATMENT COST FOR MEDI-CAL PATIENTS WITH SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PDB16 IMPACT OF NOVOLOG EXTENDED DRUG STABILITY ON HEALTH PLAN EXPENDITURES FOR INSULIN AND SUPPLIES IN PUMP USERS

    May 1, 2010, 00:00

  • PCN45 HEALTH CARE RESOURCE UTILIZATION (HRU) IN ADVANCED OVARIAN CANCER-FINDINGS FROM LINKED SEER-MEDICARE DATA

    May 1, 2010, 00:00

  • PND35 ANTIEPILEPTIC DRUG UTILIZATION AND MEDICAID REIMBUSEMENT TRENDS FROM 1991 TO 2008

    May 1, 2010, 00:00

  • PIH16 COST-EFFECTIVENESS ANALYSIS FOR TREATMENT OF SYMPTOMATIC UTERINE FIBROIDS AMONG PREMENOPAUSAL WOMEN SEEKING TO RETAIN UTERUS

    May 1, 2010, 00:00

  • PIN4 IMPACT OF SUSTAINED VIROLOGICAL RESPONSE (SVR) ON LIFE EXPECTANCY AND QUALITY-ADJUSTED LIFE-YEARS (QALYS) IN CHRONIC HEPATITIS C (CHC) PATIENTS

    May 1, 2010, 00:00

  • PDB17 THE HEALTH CARE COSTS OF LONG-ACTING INSULIN ANALOGS COMPARED WITH NPH INSULIN IN PATIENTS WITH TYPE 2 DIABETES USING A BASAL REGIMEN- A DANISH PERSPECTIVE

    May 1, 2010, 00:00

  • PCV6 A META-ANALYSIS OF EFFICACY OF ATORVASTATIN IN COMPARISON TO PRAVASTATIN, SIMVASTATIN AND ROSUVASTATIN FOR THE CONTROL OF DYSLIPIDEMIA AND CARDIOVASCULAR EVENTS PREVENTION

    May 1, 2010, 00:00

  • PSY55 IS HOSPITAL EXPERIENCE ASSOCIATED WITH BETTER IN-HOSPITAL OUTCOMES AMONG SICKLE CELL PATIENTS WITH ACUTE CHEST SYNDROME- RESULTS FROM A NATIONAL DATABASE

    May 1, 2010, 00:00

  • PCN20 INFUSION REACTIONS IN PATIENTS TREATED WITH ANTI-EGFR MONOCLONAL ANTIBODY THERAPIES FOR METASTATIC COLORECTAL CANCER- RATES AND IMPACT FROM LITERATURE REVIEW

    May 1, 2010, 00:00

  • PUK15 COST-EFFECTIVENESS ANALYSIS OF THREE MONTHS TREATMENT WITH FESOTERODINE COMPARED TO GENERIC OXYBUTYNIN EXTENDED-RELEASE IN WOMEN WITH URINARY INCONTINENCE FROM A THIRD PARTY PAYER PERSPECTIVE

    May 1, 2010, 00:00

  • PHP74 RISK SHARING- WHATS BEING SHARED

    May 1, 2010, 00:00

  • PCN70 ECONOMIC EVALUATION ON THE USE OF PLERIXAFOR ALONGSIDE THE GRANULOCYTE-COLONY STIMULATING FACTOR (GCSF) IN PREPARATION FOR AN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION ON PATIENTS WITH NON HODGKINS LYMPHOMA

    May 1, 2010, 00:00

  • PIN6 COST-ANALYSIS OF LEVOFLOXACIN IV COMPARED TO OTHER GUIDELINE-ENDORSED THERAPIES FOR PATIENTS HOSPITALIZED WITH COMMUNITY-ACQUIRED PNEUMONIA

    May 1, 2010, 00:00

  • PCN83 COST-EFFECTIVENESS OF LENOGRASTYM ON NEUTROPENIA DURATION IN ADULTS RECEIVING CHEMOTHERAPY FOR SOLID TUMORS OR LYMPHOMAS

    May 1, 2010, 00:00

  • PND13 A SYSTEMATIC REVIEW OF ECONOMIC ANALYSES OF RASAGILINE AND ENTACAPONE IN PARKINSONS DISEASE

    May 1, 2010, 00:00

  • RM4 CONFOUNDING EFFECT OF AGE IN THE ASSOCIATION OF CARDIOVASCULAR RISK AND DIETARY SUPPLEMENT USE AMONG US ADULTS

    May 1, 2010, 00:00

  • PDB7 GLYCAEMIC CONTROL AND INSULIN UTILISATION IN PATIENTS WITH TYPE 2 DIABETES INITIATED ON A LONG-ACTING INSULIN ANALOGUE IN A DUTCH REAL-LIFE SETTING

    May 1, 2010, 00:00

  • PSY32 COST-EFFECT ANALYSIS OF THE USE OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES COMPARED TO FLUCONAZOLE AND ITRACONAZOLE IN PATIENTS WITH PRONOUNCED NEUTROPENIA

    May 1, 2010, 00:00

  • PND6 MODELING THE ESTIMATED COST-SAVINGS OF STRATIFIED CARE FOR MIGRAINE HEADACHES FROM A U.S. PERSPECTIVE

    May 1, 2010, 00:00

  • PSS18 THE IMPACT OF THE IPLEDGE PROGRAM ON ISOTRETINOIN FETAL EXPOSURE

    May 1, 2010, 00:00

  • PCV132 COST-EFFECTIVENESS OF PERFUSION IMAGING WITH COMPUTED TOMOGRAPHY TO IDENTIFY PATIENTS FOR INTRAVENOUS THROMBOLYSIS- A HOSPITAL PERSPECTIVE

    May 1, 2010, 00:00

  • PCN148 YEAR ONE EVALUATION OF PARTICIPATION AND COMPLIANCE IN REGIONAL PAY FOR QUALITY (P4Q) ONCOLOGY PROGRAM

    May 1, 2010, 00:00

  • PHP14 ACCESS WITH EVIDENCE DEVELOPMENT SCHEMES- A FRAMEWORK FOR THEIR DESIGN AND EVALUATION

    May 1, 2010, 00:00

  • PMS12 COST OF SECOND FRACTURE AMONG MEDICARE PATIENTS WITH INITIAL HIP, VERTEBRAL, AND NON-HIP NON-VERTEBRAL (NHNV) FRACTURES

    May 1, 2010, 00:00

  • PCN62 COST EFFECTIVENESS OF RADICAL PROSTATECTOMY VERSUS WATCHFUL WAITING FOR NON-SCREEN DETECTED PROSTATE CANCER- EXTRAPOLATING FROM THE SCANDINAVIAN TRIAL

    May 1, 2010, 00:00

  • PCN126 INEQUALITY OF FORMULARY COVERAGE OF COLORECTAL CANCER DRUGS AMONG TAIWANS NATIONAL HEALTH INSURANCE HOSPITALS

    May 1, 2010, 00:00

  • PIN25 COST-EFFECTIVENESS ANALYSIS OF ERTAPENEN VS THE PATTERS OF ANTIBIOTICS ROUTINELY USED FOR THE TREATMENT OF DIABETIC FOOT INFECTIONS AT THE SOCIAL SECURITY MEXICAN INSTITUTE

    May 1, 2010, 00:00

  • PCV77 COST EFFECTIVENESS ANALYSIS THE PREVENTION OF VENOUS THROMBOEMBOLISM IN IMMOBILIZED PATIENTS (PREVENT) TRIAL- THROMBOPROPHYLACTIC TREATMENT WITH DALTEPARIN VERSUS PLACEBO IN ACUTELY ILL PATIENTS

    May 1, 2010, 00:00

  • PMH55 CANADIAN COST-EFFECTIVENESS ANALYSIS OF LONG-ACTING RISPERIDONE VERSUS ORAL ATYPICAL AND CONVENTIONAL DEPOT ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA AT HIGH-RISK OF NON-COMPLIANCE- UPDATED BASED ON NEW CLINICAL DATA

    May 1, 2010, 00:00

  • PHP52 PREVALENCE AND PREDICTORS OF UNINTENTIONAL NON-ADHERENCE AMONG ADULTS WITH CHRONIC DISEASE WHO SELF-IDENTIFY AS BEING ADHERENT TO PRESCRIPTION MEDICATIONS

    May 1, 2010, 00:00

  • PDB76 AN OPEN-SOURCE, INTERACTIVE MODEL TO ASSESS THE OUTCOMES AND ECONOMICS OF DIABETES INTERVENTIONS IN CANADA

    May 1, 2010, 00:00

  • PCV115 A SYSTEMATIC REVIEW OF QUALITY OF LIFE ASSESSMENT OF PATIENTS SUFFERING FROM THORACIC AORITC DISEASES

    May 1, 2010, 00:00

  • PDB42 PATIENT COMPLIANCE TO EXTENDED-RELEASE VERSUS IMMEDIATERELEASE GLIPIZIDE FOR TYPE 2 DIABETES MELLITUS- A SYSTEMATIC REVIEW

    May 1, 2010, 00:00

  • PRS18 ASSESSMENT OF THE CLINICAL AND ECONOMIC IMPACT OF AIR LEAKS DURING POST-OPERATIVE PULMONARY SURGERY

    May 1, 2010, 00:00

  • PMH19 COMPARATIVE ANALYSIS OF THE EFFICACY AND SAFETY OF ESCITALOPRAM WITH SERTRALINE AND VENLAFAXINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

    May 1, 2010, 00:00

  • PCV99 THE ROLE OF ILLNESS BURDEN AND MEDICATION BELIEFS IN MEDICATION COMPLIANCE OF ELDERLY WITH HYPERTENSION

    May 1, 2010, 00:00

  • PDB41 BELIEFS AND EXPECTATIONS ABOUT DIABETES AND MEDICATION ADHERENCE IN PERSONS WITH TYPE 2 DIABETES

    May 1, 2010, 00:00

  • PRS32 RELATIONSHIP OF COST-SHARING LEVELS TO ADHERENCE WITH DUAL-CONTROLLER THERAPY AMONG ASTHMA PATIENTS

    May 1, 2010, 00:00

  • PMC46 COMPARISON OF DIFFERENCE-IN-DIFFERENCE AND PROPENSITY SCORE METHODS IN REGRESSIONS WITH BINARY OUTCOMES

    May 1, 2010, 00:00

  • PR2 EVALUATING THE MEASUREMENT PROPERTIES OF AN AUGMENTED EQ-5D WITH THE INCLUSION OF TWO SINGLE QUALITY-OF-LIFE (QOL) INDICATORS USING THE MEDICAL EXPENDITURE PANEL SURVEY (MEPS)

    May 1, 2010, 00:00

  • PIH34 DRG 237- SPRAINS, STRAINS, THIGH

    May 1, 2010, 00:00

  • PIN16 COST-EFFECTIVENESS ANALYSIS OF MICAFUNGIN VERSUS LIPOSOMAL AMPHOTERICIN B IN THE TREATMENT OF PAEDIATRIC PATIENTS WITH SYSTEMIC CANDIDA INFECTIONS

    May 1, 2010, 00:00

  • PHP38 A FURTHER STUDY ON PREFERRED DRUG BENEFIT PLANS FOR CIVIL SERVANT MEDICAL BENEFIT SCHEME IN THAILAND

    May 1, 2010, 00:00

  • PIN33 A CLINICAL-ECONOMIC STUDY OF CASPOFUNGIN THERAPY IN THE TREATMENT OF INVASIVE CANDIDIASIS IN RESUSCITATION AND INTENSIVE CARE UNITS

    May 1, 2010, 00:00

  • PCV19 CLINICAL AND ECONOMIC IMPACT OF A PROGRAM COMBINING COMPREHENSIVE LIPID PROFILING WITH A HEART DISEASE TREATMENT PROTOCOL

    May 1, 2010, 00:00

  • PSY46 EFFECT OF ACUTE BLEEDING EPISODES ON QUALITY OF LIFE (QOL) IN PATIENTS WITH CONGENITAL HEMOPHILIA WITH INHIBITORS (CHWI) AND THEIR FAMILIES- OBSERVATIONS OF BLEED VS. NON-BLEED DAY QOL FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA ...

    May 1, 2010, 00:00

  • CM4 IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON HEALTH CARE UTILIZATION IN PATIENTS WITH COMORBID TYPE II DIABETES AND CARDIOVASCULAR DISEASE

    May 1, 2010, 00:00

  • PHP19 PREVALENCE AND PREDICTORS OF ANTIDEPRESSANT PRESCRIBING IN ELDERLY NURSING HOME RESIDENTS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PRS21 ANALYSIS OF CLINICAL EFFICACY AND DIRECT COSTS OF THE SPECIFIC IMMUNOTHERAPY IN POLAND-A THREE-YEAR RETROSPECTIVE STUDY

    May 1, 2010, 00:00

  • PND16 COST SAVING OPPORTUNITY OF POTENTIAL PHARMACIST-INITIATED IV-TO-PO LEVETIRACETAM SWITCHES- A PREDICTION MODEL BASED ON REAL-WORLD DATA

    May 1, 2010, 00:00

  • PHP58 ASSESSMENT OF PHARMACOECONOMIC EVALUATIONS SUBMITTED FOR REIMBURSEMENT SINCE KOREAN POSITIVE LIST SYSTEM INTRODUCTION

    May 1, 2010, 00:00

  • PRS41 NATIONAL ANTI-ALLERGIC DRUG UTILIZATION PATTERNS IN ADULTS WITH ALLERGIC RHINITIS- NATIONAL AMBULATORY CARE SURVEY RESULTS.

    May 1, 2010, 00:00

  • PCV142 COMPARATIVE EFFECTIVENESS REVIEW- DRUG-ELUTING STENTS VERSUS BARE-METAL STENTS FOR ACUTE MYOCARDIAL INFARCTION

    May 1, 2010, 00:00

  • PMH60 ADHERENCE TO MEDICATION FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)-DOES THE TIMEFRAME MATTER?

    May 1, 2010, 00:00

  • PMH18 TREATMENT PATTERNS IN ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ANALYSES WITH THE RAMQ DATABASE

    May 1, 2010, 00:00

  • PHP71 LISTING AND REIMBURSEMENT OF NEW DRUGS IN NATIONAL HEALTH INSURANCE-AN EMPIRICAL EXPERIENVCE OF TAIWAN

    May 1, 2010, 00:00

  • PRS2 A NOVEL METHODOLOGY FOR MEASURING THE INFLUENCE OF COMORBIDITY IN HEALTH OUTCOME STUDIES

    May 1, 2010, 00:00

  • CN3 DIRECT MEDICAL COSTS OF TREATMENT OF METASTATIC BREAST CANCER AFTER ANTHRACYCLINES AND TAXANES FAILURE FROM THE MEXICAN PUBLIC HEALTH SYSTEM PERSPECTIVE

    May 1, 2010, 00:00

  • CASE2 INVENTING A TIERED FORMULARY BASED ON THE INCREMENTAL COST-EFFECTIVENESS OF DRUGS

    May 1, 2010, 00:00

  • PCV2 POSTMARKETING SAFETY EVALUATION OF ALISKIREN HEMIFUMARATE, A NEW MOLECULAR ENTITY

    May 1, 2010, 00:00

  • PUK3 EVALUATION OF SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION VERSUS LIVER TRANSPLANTATION ALONE FOR END-STAGE LIVER DISEASE PATIENTS WITH IMPAIRED RENAL FUNCTION - A COMPARATIVE EFFECTIVENESS ANALYSIS

    May 1, 2010, 00:00

  • PCN13 TAXANE USE AND NEUROPATHY IN EARLY STAGE BREAST CANCER PATIENTS - RESULTS FROM A US COMMUNITY ONCOLOGY CENTER

    May 1, 2010, 00:00

  • PHP56 IMPACT OF ENROLLING IN A CONSUMER-DRIVEN HEALTH PLAN (CDHP) ON MEDICATION ADHERENCE

    May 1, 2010, 00:00

  • PCV122 IS PRESCRIBING JUSTIFIED BY THE EVIDENCE?-COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS FOR TREATING HYPERTENSIVE OUTPATIENTS IN SOUTHERN TAIWAN

    May 1, 2010, 00:00

  • PCN85 ECONOMIC MODELING FOR TREATMENT FAILURE PATIENTS USING MULTIPLE ROUNDS OF THERAPY AS COMPARATOR- CASE IN POINT LYMPHOMA DRUG CANDIDATE

    May 1, 2010, 00:00

  • PMH31 ASSESSING THE RISK OF HOSPITALIZATION AND ASSOCIATED HEALTH CARE COSTS IN PATIENTS WITH BIPOLAR DISORDER TREATED WITH ATYPICAL ANTIPSYCHOTICS

    May 1, 2010, 00:00

  • PDB56 RELATIONSHIP BETWEEN CARE FINANCING STRUCTURE AND DIABETES CARE ASSESSMENTS AMONG MEDICAID BENEFICIARIES WITH TYPE 2 DIABETES

    May 1, 2010, 00:00

  • PCV28 TEN-YEAR TRENDS IN STATIN USE AMONG ELDERLY WOMEN

    May 1, 2010, 00:00

  • PHP43 PROCEDURES WITH THE MOST RAPIDLY INCREASING HOSPITAL COSTS, 2004-2007

    May 1, 2010, 00:00

  • PRS39 ASSESSING DEMOGRAPHIC DISPARITIES IN UTILIZATION OF INHALED CORTICOSTEROIDS AMONG PATIENTS WITH PERSISTENT ASTHMA

    May 1, 2010, 00:00

  • PMS68 DOSES AND INFUSION INTERVALS FOR INFLIXIMAB IN ANTI-TNF NAiVE AND ANTI-TNF EXPERIENCED MANAGED CARE PATIENTS WITH RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00

  • PDB65 IMPROVED PATIENT OUTCOMES RESULTING FROM PHYSICIANS* THERAPY DECISIONS BASED ON PHARMACISTS RECOMMENDATIONS

    May 1, 2010, 00:00

  • PMH59 SYSTEM DYNAMICS SIMULATION FOR ACUTE SCHIZOPHRENIA TREATMENT

    May 1, 2010, 00:00

  • PCN32 RECENT ERYTHROPOIESIS STIMULATING AGENT (ESA) UTILIZATION AND COSTS IN MEDICARE PATIENTS WITH CANCER RECEIVING CHEMOTHERAPY (CRC)

    May 1, 2010, 00:00

  • PMC18 ELECTRONIC PRO VERSUS PAPER PRO- WHAT DO THE PATIENTS THINK?

    May 1, 2010, 00:00

  • PSY31 CLINICAL-ECONOMIC EVALUATION OF AZACITIDINE VERSUS DECITABINE FOR TREATING PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)

    May 1, 2010, 00:00

  • PDB12 PREDICTORS OF STATIN USE AMONG OVERWEIGHT AND OBESE ADULTS IN AMBULATORY CARE SETTING IN THE UNITED STATES

    May 1, 2010, 00:00

  • PIH23 OVERVIEW OF THE DEVELOPMENT PHASES OF THE OXFORD ANKLE FOOT QUESTIONNAIRE FOR CHILDREN

    May 1, 2010, 00:00

  • PMH47 THE ECONOMIC IMPACT OF ARIPIPRAZOLE AMONG PERSONS WITH SCHIZOPHRENIA IN MEXICO

    May 1, 2010, 00:00

  • PCV107 PATIENT ADHERENCE TO CHRONIC DISEASE MEDICATIONS IN A MEDICATION THERAPY MANAGEMENT PROGRAM

    May 1, 2010, 00:00

  • PCN81 THE COST-EFFECTIVENESS ANALYSIS OF SEMI-ANNUAL SCREENING FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHORNIC HEPATITIS B

    May 1, 2010, 00:00

  • PUK7 IMMUNOSUPPRESSANT THERAPY PATTERNS AND ITS COSTS IN POST KIDNEY TRANSPLANT PATIENTS IN THE NATIONAL TRANSPLANT PROGRAM IN BRAZIL

    May 1, 2010, 00:00

  • PSY60 LARGE-SCALE, PROSPECTIVE, OBSERVATIONAL STUDIES IN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS- A SYSTEMATIC AND CRITICAL REVIEW.

    May 1, 2010, 00:00

  • PGI10 PATIENT FINANCIAL BURDEN, SURGICAL COSTS AND REIMBURSEMENTS FOR OPEN AND LAPAROSCOPIC COLECTOMY PROCEDURES IN DIVERTICULAR DISEASE

    May 1, 2010, 00:00

  • PCASE5 DEVELOPMENT OF A COOPERATIVE PHYSICIAN-PHARMACIST MEDICATION THERAPY MANAGEMENT MODEL FOR THE POLYPHARMACY ELDERLY IN TAIWAN

    May 1, 2010, 00:00

  • HT2 VARIABILITY IN UTILIZATION OF INNOVATIVE DRUGS IN EUROPE AS A RESULT OF HEALTH TECHNOLOGY ASSESSMENT AND FUNDING PROCEDURES- EXAMPLES OF TRASTUZUMAB AND CETUXIMAB

    May 1, 2010, 00:00

  • PMC13 THE COST-EFFECTIVENESS SENSITIVITY CURVE- QUANTIFYING THE EFFECT OF INDIVIDUAL PARAMETER UNCERTAINTY IN A PROBABILISTIC MODEL

    May 1, 2010, 00:00

  • PHP55 A SHORT 10-ITEM MEASURE OF COLLABORATIVE CLINICAL TEAM WORKING- THE WORKING IN HEALTH CARE QUESTIONNAIRE (WHQ-10)

    May 1, 2010, 00:00

  • PMS50 EXAMINATION OF PATIENT CHARACTERISTICS, COMORBIDITIES AND CONCOMITANT MEDICATION USE IN TWO DISTINCT PATIENT POPULATIONS WITH RHEUMATOID ARTHRITIS (RA) USING A VALIDATED DATA ANALYSIS TOOL

    May 1, 2010, 00:00

  • PRS42 IMPACT OF THE UK PUBLIC SMOKING BAN ON THE PRESCRIBING OF SMOKING CESSATION THERAPY IN PRIMARY CARE^A THIN DATABASE STUDY

    May 1, 2010, 00:00

  • PMC6 USE OF CLINICAL SIMULATION CENTERS TO CONDUCT PATIENTCENTERED TIME-AND-MOTION SIMULATIONS AS A BASIS FOR ECONOMIC ANALYSIS

    May 1, 2010, 00:00

  • PSY53 INTRAGASTRIC BALOON (IGB) FOR MORBIDLY OBESE (MOP) AND SUPER OBESE PATIENTS (SOP) - SYSTEMATIC REVIEW (SR) AND HEALTH TECHNOLOGY ASSESSMENT (HTA)

    May 1, 2010, 00:00

  • PMC5 VALIDATING A WEB-BASED INCREMENTAL COST-EFFECTIVENESS SOFTWARE PROGRAM THAT USES A MARKOV TRANSITION PROBABILITY MATRIX ANALYSIS MODEL

    May 1, 2010, 00:00

  • PGI34 TREATMENT SATISFACTION WITH MEDICATIONS FOR GASTROESOPHAGEAL REFLUX DISEASE- RESULTS FROM A LARGE DISEASE REGISTRY

    May 1, 2010, 00:00

  • PMH17 OUTCOME TRAJECTORIES IN THE LONG-TERM TREATMENT OF SCHIZOPHRENIA

    May 1, 2010, 00:00

  • PHP4 IMPROVING ACCESS-TO-CARE LEADS TO OPTIMAL OUTCOMES IN PHARMACIST-LED MEDICATION THERAPY MANAGEMENT (MTM) PROGRAM

    May 1, 2010, 00:00

  • PRS43 PRESCRIBING ANTIBIOTICS FOR ACUTE RESPIRATORY TRACT INFECTIONS BY PRIMARY CARE PHYSICIANS IN NEW DELHI, INDIA

    May 1, 2010, 00:00

  • PIH31 A STUDY OF THE EFFECT OF MEDICAID COVERAGE ON CHILDRENS HEALTH

    May 1, 2010, 00:00

  • PDB66 EVALUATION OF SELECTED COMPREHENSIVE DIABETES CARE MEASURES IN A MANAGED CARE DATABASE BY USING THE RETROSPECTIVE ANALYSIS FOR DIABETES ACTION AND REPORTING TOOL

    May 1, 2010, 00:00

  • PCN106 IMPACT OF AN INDIVIDUALS LOCUS OF CONTROL ON UTILITY VALUES FOR HEAD AND NECK CANCER HEALTH STATES

    May 1, 2010, 00:00

  • PHP105 THE UTILIZATION OF PARENTERAL NUTRITION IN THE UNITED STATES

    May 1, 2010, 00:00

  • PCV68 COST-EFFECTIVENESS OF GENOTYPE-DRIVEN ANTIPLATELET THERAPY FOR SECONDARY PREVENTION AFTER ACUTE CORONARY SYNDROME

    May 1, 2010, 00:00

  • PMC39 TAPPING INTO A NEW DATA COLLECTION PARADIGM- USING DIRECT TO PATIENT PROGRAMS FOR MORE COST EFFECTIVE STUDY MANAGEMENT

    May 1, 2010, 00:00

  • PIN31 COST-EFFECTIVENESS OF THREE ANTIRETROVIRAL SCHEMES AFTER A FIRST VIROLOGICAL FAILURE IN PATIENTS WITH HIV/AIDS IN COLOMBIA

    May 1, 2010, 00:00

  • PHP94 ASSOCIATION OF SURGEON AND HOSPITAL CHARACTERISTICS AND PRESENCE OF A PERIOPERATIVE CARE PATHWAY FOR ELECTIVE BOWEL RESECTION WITH LENGTH OF STAY AFTER LAPAROSCOPIC SURGERY; RESULTS OF A NATIONAL SURVEY

    May 1, 2010, 00:00

  • PCV29 THROMBOPROPHYLAXIS OF PATIENTS RECEIVING TOTAL KNEE REPLACEMENT- 1998-2002 VERSUS 2003-2007

    May 1, 2010, 00:00

  • DISCLOSURE INFORMATION

    May 1, 2010, 00:00

  • PMH88 ASSOCIATION OF PATIENT CHARACTERISTICS WITH THE USE OF PHARMACOTHERAPY, PSYCHOTHERAPY AND COMBINED TREATMENT FOR DEPRESSION

    May 1, 2010, 00:00

  • PCV9 CLINICAL RELEVANCE OF PHARMACOLOGICAL INTERACTIONS

    May 1, 2010, 00:00

  • PSY39 WHAT ARE THE KEY ATTRIBUTES AND ENDPOINTS OF OVERWEIGHT AND OBESITY THERAPY? A CONCEPTUAL MAP OF PATIENT-CENTRED OUTCOMES

    May 1, 2010, 00:00

  • CE1 COST-EFFECTIVENESS OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM INSULIN GLARGINE TO INSULIN DETEMIR IN A CHINESE SETTING- A HEALTH ECONOMIC MODEL BASED ON THE PREDICTIVE STUDY

    May 1, 2010, 00:00

  • PGI30 PSYCHOMETRIC PROPERTIES OF THE TREATMENT SATISFACTION QUESTIONNAIRE FOR MEDICATION IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE

    May 1, 2010, 00:00

  • PMH65 ADHERENCE AND PERSISTENCE TO TREATMENT IN PATIENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ANALYSES WITH THE RAMQ DATABASE

    May 1, 2010, 00:00

  • PSY41 PATIENT AND CAREGIVER-REPORTED SYMPTOMS AND REASONS FOR STARTING/STOPPING RECOMBINANT FACTOR VIIA (RFVIIA) TREATMENT- OBSERVATIONS FROM THE DOSING OBSERVATIONAL STUDY IN HEMOPHILIA (DOSE)

    May 1, 2010, 00:00

  • PDB59 TIME TO OPIOID USE AMONG COMMERCIALLY-INSURED PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN WHO INITIATED DULOXETINE VERSUS OTHER TREATMENTS

    May 1, 2010, 00:00

  • PMH61 ADHERENCE AND PERSISTENCE WITH MEDICATION THERAPY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER- A REAL-WORLD COMPARISON OF BRANDED ANTIDEPRESSANTS AND GENERIC SSRIS

    May 1, 2010, 00:00

  • PHP100 INDEPENDENT RETAIL PHARMACY ATTRIBUTES, INSURER REIMBURSEMENT, AND THE IMPLICATION ON THE PROPOSED COLLECTIVE BARGAINING LAW

    May 1, 2010, 00:00

  • PMS13 INCREMENTAL MEDICAL COST OF MUSCOLOSKELETAL DISORDERS IN THE UNITED STATES- ESTIMATES FROM 2006 MEDICAL EXPENDITURE PANEL SURVEY (MEPS) DATA

    May 1, 2010, 00:00

  • PCV21 A BENEFIT-RISK ASSESSMENT OF USING CYP2C19 GENOTYPE INFORMATION TO GUIDE ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME

    May 1, 2010, 00:00

  • PSS9 EFFICIENCY (COST/EFFICACY) OF BIOLOGIC AGENTS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS

    May 1, 2010, 00:00

  • PHP15 EVALUATION OF PATIENT ASSISTANCE PROGRAM AVAILABILITY AND ELIGIBILITY FOR TOP 200 BRAND AND GENERIC DRUGS IN THE UNITED STATES

    May 1, 2010, 00:00

  • PIH14 COST-EFFECTIVENESS OF A HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) VERSUS RECOMBINANT FOLLICLESTIMULATING HORMONE (RFSH) IN PATIENTS PARTICIPATING IN AN ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) PROGRAM

    May 1, 2010, 00:00

  • PDB24 COST-EFFECTIVENESS OF ROUX-EN-Y GASTRIC BYPASS IN TYPE 2 DIABETES PATIONTS IN CANADA

    May 1, 2010, 00:00

  • PMC34 SUPPLEMENTAL METHODOLOGY FOR TRANSLATING INSTRUMENTS DEVELOPED IN A LANGUAGE OTHER THAN ENGLISH

    May 1, 2010, 00:00

  • PHP29 SPATIAL DEPENDENCE (OR CLUSTER) IN TOTAL NUMBER OF PRESCRIPTION DRUGS FILLED AT RETAIL PHARMACIES IN US

    May 1, 2010, 00:00

  • PCV38 RELATIONSHIP BETWEEN ADMITTING (NON-FASTING) BLOOD GLUCOSE AND IN-HOSPITAL MORTALITY STRATIFIED BY DIABETES MELLITUS AMONG ACUTE CORONARY SYNDROME PATIENTS IN OMAN

    May 1, 2010, 00:00

  • PCV155 LINKING CLAIMS AND ELECTRONIC MEDICAL RECORD (EMR) DATA FOR A HYPERTENSION STUDY

    May 1, 2010, 00:00

  • PMC26 EVALUATING TREATMENT SATISFACTION ENDPOINT EVIDENCE FOR EMEA REGULATORY APPROVALS

    May 1, 2010, 00:00

  • PHP51 CONSUMER KNOWLEDGE AND BELIEFS REGARDING ANTIBIOTIC RESISTANCE- A TELEPHONE SURVEY AND FOCUS GROUP INTERVIEW

    May 1, 2010, 00:00

  • PCV145 IMPACT OF A SEMINAL STUDY ON PRACTICE PATTERNS- STATIN USE BEFORE AND AFTER THE JUPITER STUDY

    May 1, 2010, 00:00

  • PHP53 PATIENTS USING SPECIALTY PHARMACIES FOR A TUMOR NECROSIS FACTOR ANTAGONIST HAD GREATER REFILL ADHERENCE THAN THOSE USING A RETAIL PHARMACIES

    May 1, 2010, 00:00

  • PMS31 AN EVENT-LEVEL ANALYSIS OF PRESCRIPTION REFILL INTERVALS FOR ADALIMUMAB AND ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS

    May 1, 2010, 00:00
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139 (current)
  • 140
  • »